Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Press Releases
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ROCHE HOLDING AG
10/22ROCHE : FDA Approves Genentech's Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet..
BU
10/22ROCHE : FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for neovasc..
AQ
10/22Lymphoma Hub maintains its focus on raising the levels of global knowledge of lymphoma ..
AQ
10/22ROCHE : VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to ide..
AQ
10/21CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Services
AQ
10/21ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Third Quarter Sal..
AQ
10/20ROCHE : Nine-month 2021 Investor update
PU
10/20ROCHE : reports strong growth in the first nine months – outlook for 2021 raised - I..
PU
10/20ROCHE : Nine-month 2021 Presentation without appendix
PU
10/20ROCHE : Nine-month 2021 Presentation with appendix
PU
10/20ROCHE : reports strong growth in the first nine months – outlook for 2021 raised
AQ
10/15ROCHE : FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With E..
BU
10/15ROCHE : US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with ea..
AQ
10/15ROCHE : announces PathAI collaboration for artificial intelligence-based digital pathology..
AQ
10/14ROCHE : FDA accepts REGEN-COV (casirivimab and imdevimab) for priority review for treatmen..
PU
10/14ROCHE : Invitation to Roche's Virtual Event "Digitalization along the value chain"
PU
10/14ROCHE : New four-year data show Roche's ENSPRYNG significantly reduces debilitating relaps..
AQ
10/14ROCHE : New 4-Year Data Show Genentech's Enspryng (satralizumab-mwge) Significantly Reduce..
BU
10/14ROCHE : Gazyvaro shorter 90-minute infusion time approved in Europe for people with previo..
AQ
10/13REMINDER : Invitation to Roche's 3rd Quarter Sales 2021 Webinar
PU
10/13ROCHE : New Data up to 8-Years for Genentech's Ocrevus (ocrelizumab) Show Early and Ongoin..
BU
10/13ROCHE : Data up to 8-years for Roche's OCREVUS (ocrelizumab) show early and ongoing treatm..
AQ
10/12CombiGene and Spark Therapeutics enter exclusive, global licensing agreement for gene t..
AQ
10/11ROCHE : Chugai files for additional indications of Ronapreve for prophylaxis and treatment..
PU
10/08ROCHE : anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designati..
AQ
10/08GENENTECH : 's Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy De..
BU
10/05GENENTECH : to Present New Data on Ocrevus (ocrelizumab) in Multiple Sclerosis and Enspryn..
BU
10/05ROCHE : to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis..
AQ
10/04CHUGAI PHARMACEUTICAL : Receives Orphan Drug Designation for Hemlibra in Acquired Hemophil..
AQ
10/04CHOROIDEREMIA PIPELINE : Industry Analysis, Drugs, Pipeline, Treatment and Key Companies b..
AQ
10/01ROCHE : Phase II/III trial shows Ronapreve (casirivimab and imdevimab) significantly reduc..
AQ
09/30ROCHE : Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantl..
AQ
09/28CHUGAI PHARMACEUTICAL : Zenyaku Kogyo Co. and Chugai Pharmaceutical Co. - Anti-CD20 Monocl..
AQ
09/24ROCHE : presents new data at World Muscle Society (WMS) 2021 highlighting new advances for..
AQ
09/23ROCHE : Canadian Blood Services selects Roche Diagnostics Canada as a partner of choice fo..
AQ
09/22ROCHE : launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to..
AQ
09/21ROCHE : New Phase III Data Support the Benefit of Genentech's Tecentriq in Early-Stage Lun..
AQ
09/20ROCHE : Booster programme welcome but plans must be in place for boosters for all vaccinat..
AQ
09/20ROCHE : New Phase III Data Support the Benefit of Genentech's Tecentriq in Early-stage Lun..
BU
09/20ROCHE : New Phase III data support the benefit of Roche's Tecentriq in early-stage lung ca..
AQ
09/20ROCHE : Invitation to Roche's 3rd Quarter Sales 2021 Webinar
PU
09/17ROCHE : receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adu..
AQ
09/17ROCHE : presents first phase II data on giredestrant, a next generation selective oestroge..
PU
09/15ROCHE : opens access to pathology imaging tools to improve patient care
AQ
09/09ROCHE : signs definitive share purchase agreement with long-term partner TIB Molbiol to ex..
AQ
09/07REMINDER : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
PU
09/07ROCHE : Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Deve..
AQ
09/07ROCHE : to present data from industry leading portfolio at ESMO 2021 showing significant p..
AQ
09/07GENENTECH : to Present Data From Industry-Leading Portfolio at ESMO 2021 Showing Significa..
BU
08/30ROCHE : Partners with the Kolisi Foundation, One By One Target Covid Campaign and Transnet..
BU
08/30ROCHE : Genentech Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metasta..
AQ
08/27GENENTECH : Provides Update on Tecentriq U.S. Indication for PD-L1-Positive, Metastatic Tr..
BU
08/27ROCHE : provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-n..
AQ
08/26ROCHE : Shlomo Zalman (Sam) Bregman, a Fox News Commentator, Prominent Rabbi, and Manager ..
AQ
08/24ROCHE : Shape Therapeutics enters into a strategic research collaboration with Roche to ad..
AQ
08/23ROCHE : First monoclonal antibody treatment for COVID-19 approved for use in the UK
AQ
08/19ROCHE : Joint Statement From Unitaid and the World Health Organization (On Behalf of the A..
AQ
08/18JOHNSON & JOHNSON : WHO urges J&J to stop shipping Covid vaccines from Africa to rich coun..
AQ
08/18ROCHE : receives FDA approval for first companion diagnostic to identify dMMR solid tumour..
AQ
08/09ROCHE : Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years t..
AQ
08/09ROCHE : Phase III Study Shows Genentech's Polivy Plus R-CHP Is the First Regimen in 20 Yea..
BU
08/04ROCHE : FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatment for Cert..
AQ
08/03ROCHE : US FDA grants Priority Review to Roche's Tecentriq as adjuvant treatment for certa..
AQ
08/03ROCHE : FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatment for Cert..
BU
08/02ROCHE : FDA expands authorized use of REGEN-COV (casirivimab and imdevimab)
PU
07/30ROCHE : Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
PU
07/29PTC THERAPEUTICS : Significant Improvements in Survival and Developmental Milestones Demon..
AQ
07/29ROCHE : FDA accepts application for Roche's faricimab for the treatment of neovascular age..
AQ
07/29ROCHE : FDA Accepts Application for Genentech's Faricimab for the Treatment of Wet Age-Rel..
BU
07/29ROCHE : Data for Roche's Evrysdi® (risdiplam) published in New England Journal of Medicine..
AQ
07/28ROCHE : Data for Genentech's Evrysdi (risdiplam) Published in New England Journal of Medic..
BU
07/26ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Half Year Results..
AQ
07/22ROCHE : Half-year 2021 Investor Update
PU
07/22ROCHE : Half Year Report 2021
PU
07/22ROCHE : reports good half-year results - Investor Update
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ROCHE HOLDING AG